ORAGENICS INC — Director's Dealing 2020

Feb 7, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAGENICS INC (OGEN)
CIK: 0001174940
Period of Report: 2020-02-05

Reporting Person: DUNTON ALAN W (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-05	Non-Employee Director Option (Right to Buy)	$0.48	A	156540	Acquired	2030-02-05	Common Stock (156540)	Direct
2020-02-05	Non-Employee Director Option (Right to Buy)	$0.48	A	156540	Acquired	2030-02-05	Common Stock (156540)	Direct

Footnotes

F1: Represents an annual award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the
Company's 2012 Equity Incentive Plan, as amended (the "Plan") that vests immediately.

F2: Represents a discretionary retention award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common
stock under the Company's Plan. The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant,
February 5, 2020.